Previous studies have reported that patients with DM have higher expression of ACE2 in peripheral blood mononuclear cells [36] and cardiomyocytes [28], and upregulation of ACE2 expression could increase susceptibility to COVID-19. The gene discussed is ACE2; the disease is COVID-19.